Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury
Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury |
|
https://doi.org/10.18632/oncotarget.26207
Jonathan D. Mizrahi,
and Michael J. Overman
|
| 34857-34858 |
Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML
Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML |
|
https://doi.org/10.18632/oncotarget.26163
Salma A. Bargal,
Roya Rafiee,
Kristine R. Crews,
Huiyun Wu,
Xueyuan Cao,
Jeffrey E. Rubnitz,
Raul C. Ribeiro,
James R. Downing,
Stanley B. Pounds,
and Jatinder K. Lamba
|
| 34859-34875 |
High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy
High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy |
|
https://doi.org/10.18632/oncotarget.26172
Takuma Kagami,
Mihoko Yamade,
Takahiro Suzuki,
Takahiro Uotani,
Shinya Tani,
Yasushi Hamaya,
Moriya Iwaizumi,
Satoshi Osawa,
Ken Sugimoto,
Satoshi Baba,
Haruhiko Sugimura,
Hiroaki Miyajima,
and Takahisa Furuta
|
| 34876-34888 |
The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer
The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer |
|
https://doi.org/10.18632/oncotarget.26175
EL-Habib Dakir,
Adam Pickard,
Kirtiman Srivastava,
Cian M. McCrudden,
Stephane R. Gross,
Stephen Lloyd,
Shu-Dong Zhang,
Andriana Margariti,
Richard Morgan,
Philip S. Rudland,
and Mohamed El-Tanani
|
| 34889-34910 |
Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes
Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes |
|
https://doi.org/10.18632/oncotarget.26178
Laura Bertoccini,
Diego Bailetti,
SUMMER Study in Diabetes Group,
Raffaella Buzzetti,
Maria Gisella Cavallo,
Massimiliano Copetti,
Efisio Cossu,
Paola D'Angelo,
Salvatore De Cosmo,
Lazzaro Di Mauro,
Frida Leonetti,
Susanna Morano,
Lelio Morviducci,
Nicola Napoli,
Sabrina Prudente,
Giuseppe Pugliese,
Vincenzo Trischitta,
and Marco Giorgio Baroni
|
| 34911-34918 |
Exosomal survivin facilitates vesicle internalization
Exosomal survivin facilitates vesicle internalization |
|
https://doi.org/10.18632/oncotarget.26182
Amber Gonda,
Janviere Kabagwira,
Girish N. Senthil,
Heather R. Ferguson Bennit,
Jonathan W. Neidigh,
Salma Khan,
and Nathan R. Wall
|
| 34919-34934 |
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma |
|
https://doi.org/10.18632/oncotarget.26183
Martina Da Ros,
Anna Lisa Iorio,
Veronica De Gregorio,
Ornella Fantappiè,
Giacomo Laffi,
Maurizio de Martino,
Claudio Pisano,
Lorenzo Genitori,
and Iacopo Sardi
|
| 34935-34944 |
Mechanisms through which lithocholic acid delays yeast chronological aging under caloric restriction conditions
Mechanisms through which lithocholic acid delays yeast chronological aging under caloric restriction conditions |
|
https://doi.org/10.18632/oncotarget.26188
Anthony Arlia-Ciommo,
Anna Leonov,
Karamat Mohammad,
Adam Beach,
Vincent R. Richard,
Simon D. Bourque,
Michelle T. Burstein,
Alexander A. Goldberg,
Pavlo Kyryakov,
Alejandra Gomez-Perez,
Olivia Koupaki,
and Vladimir I. Titorenko
|
| 34945-34971 |
Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging
Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging |
|
https://doi.org/10.18632/oncotarget.26200
Claudia Duranti,
Laura Carraresi,
Angelica Sette,
Matteo Stefanini,
Tiziano Lottini,
Silvia Crescioli,
Olivia Crociani,
Luisa Iamele,
Hugo De Jonge,
Ermanno Gherardi,
and Annarosa Arcangeli
|
| 34972-34989 |
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas |
|
https://doi.org/10.18632/oncotarget.26204
Christian Posch,
Martina Sanlorenzo,
Jeffrey Ma,
Sarasa T. Kim,
Mitchell Zekhtser,
and Susana Ortiz-Urda
|
| 34990-34995 |
Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma
Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26209
Xuran Yang,
Wei Xia,
Lin Chen,
Chuan Xing Wu,
Cathy C. Zhang,
Peter Olson,
and Xiao Qi Wang
|
| 34996-35007 |
Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
|
https://doi.org/10.18632/oncotarget.26150
Ganiou Assani,
Yudi Xiong,
Fuxiang Zhou,
and Yunfeng Zhou
|
| 35008-35025 |
Correction: Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma
Correction: Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26226
Tzu-An Liu,
Yee-Jee Jan,
Bor-Sheng Ko,
Yi-Ju Wu,
Yi-Jhu Lu,
Shu-Man Liang,
Chia-Chia Liu,
Shyh-Chang Chen,
John Wang,
Song-Kun Shyue,
and Jun-Yang Liou
|
| 35026-35026 |
Correction: Interaction between physical activity, PITX1 rs647161 genetic polymorphism and colorectal cancer risk in a Korean population: a case-control study
Correction: Interaction between physical activity, PITX1 rs647161 genetic polymorphism and colorectal cancer risk in a Korean population: a case-control study |
|
https://doi.org/10.18632/oncotarget.26227
Madhawa Neranjan Gunathilake,
Jeonghee Lee,
Young Ae Cho,
Jae Hwan Oh,
Hee Jin Chang,
Dae Kyung Sohn,
Aesun Shin,
and Jeongseon Kim
|
| 35027-35027 |
